Elobixibat Synthesis via Condensation and Crystallization
Solution Overview
Problem
Current processes for preparing elobixibat and its crystalline monohydrate forms are not optimized for industrial-scale production, requiring multiple steps and chromatography, which are inefficient and unsuitable for large-scale synthesis, and result in lower yields and purity.
Innovation Solution
A process involving a condensation reaction between a carboxylic acid and an O-protected peptide, followed by deprotection, which reduces the number of steps and eliminates the need for chromatography, allowing for higher yields and purity, and includes a method to produce the crystalline monohydrate form suitable for industrial scale.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If preparative chromatography is used for purification, then purity is improved, but productivity deteriorates due to unsuitability for industrial scale production
Solution Approach 1:
The patent extracts and eliminates the chromatography step from the synthesis process by developing an alternative purification method using crystallization and filtration techniques, thereby removing the bottleneck that limited industrial scale production while maintaining product purity
Solution Approach 2:
The patent changes the purification approach from chromatography (which is difficult to scale) to crystallization and filtration (which are easily scalable), altering the physical-chemical parameters of the purification process to enable industrial production while maintaining high purity levels
2Reliability
If multiple consecutive steps are used in preparation, then reliability is improved through thorough purification, but device complexity increases and productivity decreases
Solution Approach 1:
The patent merges multiple consecutive synthetic steps into a more streamlined process by eliminating intermediate purification steps that required chromatography, reducing overall process complexity while maintaining product quality through optimized reaction conditions and alternative purification methods
3Manufacturing precision
If multiple consecutive steps with chromatography are used, then purity is improved, but loss of time increases due to multiple purification steps
Solution Approach 1:
The patent removes time-consuming chromatography steps from the synthesis pathway by replacing them with faster crystallization and filtration techniques, directly reducing the total synthesis time while preserving product purity
Solution Approach 2:
The patent skips intermediate purification steps that would consume time by using a streamlined approach where reactions are designed to proceed directly to products that can be purified rapidly through crystallization, effectively rushing through the synthesis process while maintaining quality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process efficiently produces elobixibat with higher yields and purity, suitable for industrial scale, and specifically optimizes the production of crystal modification IV, addressing the inefficiencies of previous methods by simplifying the synthesis and improving purification.
Implementation Method 1
A process involving a condensation reaction between a carboxylic acid and an O-protected peptide
Implementation Method 2
followed by deprotection, which reduces the number of steps
Implementation Method 3
the preparation of a crystalline monohydrate of elobixibat
Data Source
AI summary
The present invention relates to a process for the preparation of certain 1,5-benzothiazepine compounds, and in particular to a process for the preparation of elobixibat. The process can be carried out under mild and safe conditions and may be used to prepare elobixibat on an industrial scale. The invention also relates to a process for the preparation of a crystalline monohydrate of elobixibat.



